Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Apixaban outperforms rivaroxaban when treating patients with AFib and valvular heart disease

Researchers explored data from nearly 20,000 patients, sharing their findings in Annals of Internal Medicine.

Deepak Bhatt, MD, MPH, executive director of the interventional cardiovascular programs at Brigham and Women’s Hospital, and professor of medicine at Harvard Medical School, explained the new generation of cholesterol lowering agents and their roles in various types of patients.

VIDEO: Deepak Bhatt discusses the role of new cholesterol-lowering agents

Deepak Bhatt, MD, a professor of medicine at Harvard Medical School, details the new generation of cholesterol-lowering agents and their roles in patient care. 

transcarotid TAVR TAVI transcatheter aortic valve replacement

Transcarotid TAVR a safe alternative when femoral access is not an option

The conventional transfemoral approach is not always possible during TAVR procedures, leaving care teams with an important decision to make. 

The Medtronic SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing, providing users with another option when treating patients for bradycardia. According to Medtronic, this marks the first time the FDA has approved a device for this indication.

Medtronic cardiac lead the first to receive FDA approval for conduction system pacing

The company’s SelectSecure MRI SureScan Model 3830 cardiac lead already gained FDA approval for His-Bundle pacing back in 2018. Now, the lead is also approved for left bundle branch area pacing.

Leading cardiologists sound the alarm, say polypills could save millions of lives if made widely available

“This systemic failure is a global tragedy, as many premature deaths from CVD could be avoided,” one cardiologist said. 

Impella Heart Pump Abiomed RECOVER IV RCT cardiogenic shock

Impella heart pumps linked to improved high-risk PCI outcomes

Researchers examined data from patients who underwent high-risk PCI with either an Impella heart pump or an intra-aortic balloon pump.

New evidence that heart damage risk is much higher after COVID-19 infection than after vaccination

The new meta-analysis, published in Frontiers in Cardiovascular Medicine, included data from 58 million patients. “We hope our findings will help mitigate vaccine hesitancy and increase vaccine uptake," one researcher said. 

An updated look at how cognitive impairment affects TAVR outcomes

The connection between cognitive impairment and postoperative delirium among TAVR patients stood out as a definite concern to the study's authors.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.